Claims
- 1. An electro-medical device for increasing bone healing or bone formation in a body comprising a signal applicator for applying an electrical signal to a target area of the body, and a biologic administered to the body.
- 2. The electro-medical device of claim 1, wherein the signal applicator comprises a set of electrode pads.
- 3. The electro-medical device of claim 1, wherein the signal applicator applies the electrical signal directly to the skin of a patient.
- 4. The electro-medical device of claim 1, wherein the biologic decreases osteoclastic activity.
- 5. The electro-medical device of claim 1, wherein the electrical signal is an interferential signal.
- 6. The electro-medical device of claim 1, wherein the electrical signal increases osteoblastic activity.
- 7. The electro-medical device of claim 1, wherein the biologic is administered to the target area.
- 8. The electro-medical device of claim 1, wherein the biologic is bone morphogenic protein.
- 9. The electro-medical device of claim 1, wherein the biologic increases osteoinductive activity.
- 10. The electro-medical device of claim 1, wherein the biologic increases osteoconductive activity.
- 11. A method of promoting bone healing or bone formation in a body comprising applying an electrical signal to a target area of the body, and applying a biologic to the body.
- 12. The method of claim 11, wherein the biologic decreases osteoclastic activity.
- 13. The method claim 11, wherein the electrical signal is an interferential signal.
- 14. The method of claim 11, wherein the electrical signal increases osteoblastic activity.
- 15. The method of claim 11, wherein the biologic is administered to the target area.
- 16. A method of promoting bone healing or bone formation in a body comprising administering an osteoclastic treatment to the body to decrease osteoclastic activity, and administering an osteoblastic treatment to the body to increase osteoblastic activity.
- 17. The method of claim 16, wherein the osteoblastic treatment comprises an electrical signal.
- 18. The method claim 16, wherein the osteoblastic treatment comprises an interferential signal.
- 19. The method of claim 16, wherein the osteoclastic treatment comprises an antiresorptive agent.
RELATED APPLICATIONS
[0001] The present application is a continuation-in-part of U.S. Ser. No. 09/905,159, filed Jul. 16, 2001, which is a continuation-in-part of U.S. Ser. No. 09/679,557, filed Oct. 6, 2000, which is a continuation-in-part of U.S. Pat. No. 6,393,328, filed May 8, 2000.
Continuation in Parts (3)
|
Number |
Date |
Country |
Parent |
09905159 |
Jul 2001 |
US |
Child |
10383251 |
Mar 2003 |
US |
Parent |
09679557 |
Oct 2000 |
US |
Child |
09905159 |
Jul 2001 |
US |
Parent |
09566081 |
May 2000 |
US |
Child |
09679557 |
Oct 2000 |
US |